News

Device that could restore limb function to amputees and others who have lost the use of their arms or legs uses opti-ox reprogramm...

Our CEO was interviewed in this piece about the barriers and opportunities for scaling companies in the UK.

Featured in Technology Dispatch, bit.bio SVP of Technical Operations & Cell Manufacturing, Kathryn Golden, shares her insights int...

bit.bio received a bronze award for its participation in the Green Impact awards for sustainability.

bit.bio is supporting the iGEM team from University of Cambridge in the iGEM synbio competition.

bit.bio CEO and founder welcomes Meatable's cultured meat sausage, powered by opti-ox.

Dr Davide Danovi talks to The Academy of Medical Sciences as a FLIER participant in cross-sector leadership programme.

America is seeing huge growth in Synthetic Biology – the UK must ensure it doesn’t miss out.